Chinese Herbal Pieces Market meets the opportunity of expansion and the industry calls for the establishment of a unified standard

[market analysis of chinapharma.com] in recent years, the Chinese medicine law of the people's Republic of China, the strategic planning outline for the development of traditional Chinese medicine (2016-2030), the planning outline for "healthy China 2030" and the white paper of "Chinese medicine in China" have been published in succession A number of policy and regulatory documents specially issued for traditional Chinese medicine highlight the importance the country attaches to the development of traditional Chinese medicine It is reported that the total cost of national health will increase from the current 3 trillion yuan to 8 trillion yuan in 2020, and the scale of traditional Chinese medicine industry will reach 3 trillion to 4 trillion yuan in 2020 (Lin Jianning, director of CFDA South Institute of pharmaceutical economics, introduced the subject.) however, due to the scattered and low degree of standardization of the industry, the overall level of Chinese herbal medicine and Chinese Herbal Pieces industry is uneven, which will directly affect the long-term development of Chinese traditional medicine The industry chain of Chinese traditional medicine includes the cultivation, cultivation and collection of upstream Chinese traditional medicine, the processing and processing of midstream Chinese traditional medicine pieces, and the downstream Chinese patent medicine enterprises, Chinese traditional medicine hospitals and pharmacies Chinese traditional medicine pieces are the key link between the preceding and the following in the industry chain Opportunities for market expansion: to establish a unified standard under the guidance of the pharmaceutical registration department of the State Food and drug administration, and the CFDA South pharmaceutical Economic Research Institute invited mainstream Chinese medicine enterprises to jointly promote At the kick-off meeting of "development and supervision of Chinese Herbal Pieces industry", Lin Jianning, director of CFDA South Institute of pharmaceutical economics, introduced that China's Chinese Herbal Pieces industry has a long history, but there is still a lot of room for development First of all, the record of Chinese Herbal Pieces processing began in the Warring States period, but the current industry differentiation is complex, including traditional pieces, Chinese herbal formula particles, Chinese herbal pieces and delicate pieces The second is that the concentration of the industry is low, the production enterprises of the beverage industry are small as a whole, the industry presents pyramid distribution, and the small enterprises account for the vast majority, and the competition is fierce The third is the loss of resources At present, cross regional planting in the form of "agricultural and sideline products" has seriously reduced the quality of some varieties What's more, due to the regional differences and quality differences of Chinese herbal medicine resources, the industry standard depends on many subjective factors, so it is necessary to further strengthen the unity of Chinese herbal medicine standards, improve the inspection standards, and further promote the quality standards of Chinese herbal medicine; fourthly, the industry innovation is insufficient and the direction is fuzzy On the one hand, the resources of traditional Chinese medicine are gradually scarce and the utilization rate is low; on the other hand, the industry technology of traditional Chinese medicine pieces can not meet the multi-level functional requirements of clinical treatment, disease prevention, health care Lin Jianning said that whether to adhere to the traditional tunnel or to find another way? How to deal with changes in supervision? How to standardize management to promote the healthy development of the industry? All these are the focus of this research Grafting of traditional Chinese medicine with modern science and technology: good traditions cannot be completely abandoned According to the national positioning of traditional Chinese medicine industry, the volume of traditional Chinese medicine industry will reach 3 trillion-4 trillion in 2020 According to the data of the National Bureau of statistics, in 2016, the sales revenue of Chinese Herbal Pieces industry was 192.2 billion yuan, accounting for a low proportion (6.5%) in the pharmaceutical industry, but the growth rate was fast (13.1%), higher than the overall growth rate of the pharmaceutical economy, showing a good momentum of development In recent years, the international demand for traditional Chinese medicine, especially for botanical drugs, has shown a rapid growth momentum The share of botanical drugs in the international market has reached 40 billion US dollars, with an annual growth rate of nearly 20% At present, 4 billion people in the world use herbal products, accounting for 80% of the world's total population Zhang Shichen, vice president of China Association of traditional Chinese medicine and director of professional committee of decoction pieces of traditional Chinese medicine, said that China urgently needs to standardize the production process of decoction pieces of traditional Chinese medicine, establish the standard system of decoction pieces of traditional Chinese medicine, and introduce modern scientific and technological innovation and development on the basis of inheriting the tradition He pointed out that in the traditional Chinese medicine system, China should not completely abandon the things of its ancestors, but have national confidence Li Jiangning, director of the general office of the pharmaceutical registration department of the State Food and drug administration, said that in 2016, the profit of the Chinese Herbal Pieces industry was 14 billion yuan, an increase of 13.3% year on year, accounting for 4.6% of the total profit of the pharmaceutical industry The composite growth rate of the sales of Chinese Herbal Pieces industry reached 21.7%, and the proportion of sales rose to 6.5% The industry position has been steadily improved He believes that the development quality and level of the traditional Chinese medicine industry, especially the decoction pieces of traditional Chinese medicine, have a great impact on the development level of the whole pharmaceutical industry and the safety level of residents' drug use, no matter from the industrial scale or the degree of industrial activity At present, the State Food and drug administration is taking the opportunity of the reform of drug approval system to improve the efficiency of drug registration and evaluation, and strive to introduce the measures for the administration of drug registration of traditional Chinese medicine; in addition, it is further regulating the management of traditional Chinese medicine formula granules, and has completed the documents and submitted them to the State Council; In addition, we are taking the lead in organizing the preparation of the processing specifications of Chinese herbal pieces, which is the second time in the history of Chinese herbal pieces At present, we have organized the Pharmacopoeia Committee to complete part of the drafting work and publicize it to the public on the website of the Pharmacopoeia Committee.